At vise at XELOX var non- inferior i forhold til FOLFOX- 4 og at vise at Avastin i kombination med FOLFOX- 4 eller XELOX kemoterapi var bedre i forhold til kemoterapi alene.
In this study, there were two primary objectives: to show that XELOX was non-inferior to FOLFOX-4 and to show that Avastin in combination with FOLFOX-4 or XELOX chemotherapy was superior to chemotherapy alone.